Skip to content
10-Q

Quarterly Report

CRH Medical Corp

0001564590-20-053624

← back to feed
Filed
Nov 12, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 11, 2020 71.41M sh
Shares Diluted Q3 2020 · Sep 30, 2020 71.51M sh
Shares Diluted Q3 2020 · Sep 30, 2020 71.56M sh
Shares Diluted Q3 2020 · Sep 30, 2019 72.8M sh
Shares Diluted Q3 2020 · Sep 30, 2019 73.02M sh
Capex Q3 2020 · Sep 30, 2020 $10.96K
Capex Q3 2020 · Sep 30, 2020 $32.83K
Capex Q3 2020 · Sep 30, 2019 $4.83K
Capex Q3 2020 · Sep 30, 2019 $45.68K
Operating Cash Flow Q3 2020 · Sep 30, 2020 $7.82M
Operating Cash Flow Q3 2020 · Sep 30, 2020 $24.8M
Operating Cash Flow Q3 2020 · Sep 30, 2019 $10.71M
Operating Cash Flow Q3 2020 · Sep 30, 2019 $32.67M
Long Term Debt Q3 2020 · Sep 30, 2020 $75.85M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $5.1M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $6.57M
Stockholders Equity Q3 2020 · Sep 30, 2020 $72.27M
Stockholders Equity Q3 2020 · Dec 31, 2019 $76.31M
Current Liabilities Q3 2020 · Sep 30, 2020 $11.19M
Current Liabilities Q3 2020 · Dec 31, 2019 $10.34M
Current Assets Q3 2020 · Sep 30, 2020 $29.44M
Current Assets Q3 2020 · Dec 31, 2019 $29.02M
Total Assets Q3 2020 · Sep 30, 2020 $214.25M
Total Assets Q3 2020 · Dec 31, 2019 $203.1M
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.01
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.07
Eps Diluted Q3 2020 · Sep 30, 2019 $0.01
Eps Diluted Q3 2020 · Sep 30, 2019 $0.04
Eps Basic Q3 2020 · Sep 30, 2020 −$0.01
Eps Basic Q3 2020 · Sep 30, 2020 −$0.07
Eps Basic Q3 2020 · Sep 30, 2019 $0.01
Eps Basic Q3 2020 · Sep 30, 2019 $0.04
Operating Income Q3 2020 · Sep 30, 2020 $84.83K
Operating Income Q3 2020 · Sep 30, 2020 −$10.56M
Operating Income Q3 2020 · Sep 30, 2019 $3.71M
Operating Income Q3 2020 · Sep 30, 2019 $12.12M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $30.26M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $79.95M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $26.7M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $77.89M
Revenue Q3 2020 · Sep 30, 2020 $30.35M
Revenue Q3 2020 · Sep 30, 2020 $69.39M
Revenue Q3 2020 · Sep 30, 2019 $30.41M
Revenue Q3 2020 · Sep 30, 2019 $90.02M